Daniel Bensen, Chief Discovery Officer at Tyra Biosciences, Inc. (TYRA), sold 8,000 shares at $31.50 ($263K) on 2026-02-12, disclosed to the SEC on 2026-02-13.
Scheduled sale ($263k) by Chief Discovery Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.50 | 2,128 | $67K | 25.5% |
| 2 | $33.37 | 5,872 | $196K | 74.5% |
| Total | $32.87 avg | 8,000 | $263K | 100% |
| Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |
| TYRA | SELL | 2024-06-10 | $74K | — | Filing → |